Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Targeted Delivery of Anticancer Drug Loaded Charged Plga Polymeric Nanoparticles Using Electrostatic Field Publisher Pubmed



Miraghaie SH1, 2, 3 ; Zandi A2, 4 ; Davari Z2, 3 ; Mousavikiasary MS2 ; Saghafi Z2 ; Gilani A2 ; Kordehlachin Y2 ; Shojaeian F2, 5 ; Mamdouh A2 ; Heydari Z6 ; Dorkoosh FA3 ; Kaffashi B7 ; Abdolahad M2, 3, 8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Polymer Engineering, University of Tehran, Kish International Campus, Kish Island, 79416-55664, Iran
  2. 2. Nano Electronic Center of Excellence, Nano-bioelectronic Devices Lab., Cancer Electronics Research Group, School of Electrical and Computer Eng., College of Engineering, University of Tehran, Tehran, 14395–515, Iran
  3. 3. Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, 14176-14411, Iran
  4. 4. Nano Electronic Center of Excellence, Nano-electronics and Thin Film Lab., School of Electrical and Computer Eng., College of Engineering, University of Tehran, Tehran, 14395–515, Iran
  5. 5. School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, 19615-1179, Iran
  6. 6. Preclinical lab, Core facility, Tehran University of Medical Sciences, Tehran, 14174-66191, Iran
  7. 7. Department of Polymer Engineering, School of Chemical Engineering, College of Engineering, University of Tehran, Tehran, 11155-4563, Iran
  8. 8. Cancer Institute, Tehran University of Medical Sciences, Tehran, 1416753955, Iran

Source: Macromolecular Bioscience Published:2023


Abstract

Pure positive electrostatic charges (PPECs) show suppressive effect on the proliferation and metabolism of invasive cancer cells without affecting normal tissues. PPECs are used for the delivery of drug-loaded polymeric nanoparticles (DLNs) capped with negatively charged poly(lactide-co-glycolide) (PLGA) and Poly(vinyl-alcohol) PVA into the tumor site of mouse models. The charged patch is installed on top of the skin in the mouse models' tumor region, and the controlled selective release of the drug is assayed by biochemical, radiological, and histological experiments on both tumorized models and normal rats' livers. It is found that DLNs synthesized by PLGA show great attraction to PPECs due to their stable negative charges, which would not degrade immediately in blood. The burst and drug release after less than 48h of this synthesized DLNs are 10% and 50%, respectively. These compounds can deliver the loaded-drug into the tumor site with the assistance of PPECs, and the targeted-retarded release will take place. Hence, local therapy can be achieved with much lower drug concentration (conventional chemotherapy [2 mg kg−1] versus DLNs-based chemotherapy [0.75 mg kg−1]) with negligible side effects in non-targeted organs. PPECs have many potential clinical applications for advanced-targeted chemotherapy with the lowest discernible side effects. © 2023 Wiley-VCH GmbH.